Related references
Note: Only part of the references are listed.Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
Abdelhakim Bouyahya et al.
PHARMACEUTICALS (2022)
Identification of mercaptoacetamide-based HDAC6 inhibitors via a lean inhibitor strategy: screening, synthesis, and biological evaluation
Silke Geurs et al.
CHEMICAL COMMUNICATIONS (2022)
Paradigm shift of classical HDAC inhibitors to hybrid HDAC inhibitors in therapeutic interventions
Gargi Nikhil Vaidya et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina et al.
CHEMMEDCHEM (2021)
Epigenetic enzymes: A role in aging and prospects for pharmacological targeting
Elena G. Pasyukova et al.
AGEING RESEARCH REVIEWS (2021)
Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy
Yuki Maemoto et al.
JOURNAL OF ANTIBIOTICS (2021)
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
M. Janaki Ramaiah et al.
LIFE SCIENCES (2021)
Vorinostat (SAHA) and Breast Cancer: An Overview
Anna Wawruszak et al.
CANCERS (2021)
Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
Simona Izzo et al.
NUTRIENTS (2020)
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
Joshua P. Smalley et al.
MOLECULES (2020)
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Lourdes Hontecillas-Prieto et al.
FRONTIERS IN GENETICS (2020)
Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
Xiaopeng Peng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding
Bernardina Scafuri et al.
BIOMEDICINES (2020)
Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study
Jan Walewski et al.
LEUKEMIA & LYMPHOMA (2019)
Small molecule HDAC inhibitors: Promising agents for breast cancer treatment
Meiling Huang et al.
BIOORGANIC CHEMISTRY (2019)
Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
Heba M. Hesham et al.
MEDICINAL RESEARCH REVIEWS (2018)
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors
Rekha Sangwan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Catalytic enantioselective one-pot approach to cis- and trans-2,3-diaryl substituted 1,5-benzothiazepines
Sara Meninno et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
Synthesis of Potent and Selective HDAC6 Inhibitors Bearing a Cyclohexane- or Cycloheptane-Annulated 1,5-Benzothiazepine Scaffold
Rob De Vreese et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis
Chien-Yi Lu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas
Douglas W. Sborov et al.
LEUKEMIA & LYMPHOMA (2017)
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
Manuela Terranova-Barberio et al.
ONCOTARGET (2017)
Catalytic Enantioselective Synthesis of Protecting-Group-Free 1,5-Benzothiazepines
Sara Meninno et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Inhibitors of histone deacetylase as antitumor agents: A critical review
Mohammed Manal et al.
BIOORGANIC CHEMISTRY (2016)
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Yang Hai et al.
NATURE CHEMICAL BIOLOGY (2016)
Insights into the activation mechanism of class I HDAC complexes by inositol phosphates
Peter J. Watson et al.
NATURE COMMUNICATIONS (2016)
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
Elizabeth E. Hull et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Panobinostat for the Treatment of Multiple Myeloma
Jacob P. Laubach et al.
CLINICAL CANCER RESEARCH (2015)
Benzothiazepines: chemistry of a privileged scaffold
Debasmita Saha et al.
RSC ADVANCES (2015)
Structural basis for the design and synthesis of selective HDAC inhibitors
Simone Di Micco et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Potent and selective HDAC6 inhibitory activity of N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorenes as novel sulfur analogues of Tubastatin A
Rob De Vreese et al.
CHEMICAL COMMUNICATIONS (2013)
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
Silvia Consalvi et al.
MOLECULAR MEDICINE (2013)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
Structure of HDAC3 bound to co-repressor and inositol tetraphosphate
Peter J. Watson et al.
NATURE (2012)
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
Jerome C. Bressi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Inside HDAC with HDAC inhibitors
Philippe Bertrand
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Antiproliferative and Differentiating Activities of a Novel Series of Histone Deacetylase Inhibitors
Monica Binaschi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
1,5-Benzothiazepine, a versatile pharmacophore: A review
Jitender B. Bariwal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain
Matthew J. Bottomley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity
Anja Schuetz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases
JR Somoza et al.
STRUCTURE (2004)
Share Paper
